Mental Health and Physical Function of Persons Age 50 and Older Seeking Treatment for Substance Use Disorders
Lisa Barry,Kristyn Zajac,Megan O'Grady,Alexandra DePalma,Lance Bauer
DOI: https://doi.org/10.1016/j.jagp.2024.01.213
IF: 7.996
2024-02-21
American Journal of Geriatric Psychiatry
Abstract:Introduction Substance use disorders (SUDs) among persons in mid-to-late life (age ≥50) are among the fastest growing health problems in the U.S. Studies suggest that persons with SUDs may experience early onset of age-related diseases. Yet, this "accelerated aging" may also manifest as geriatric conditions (e.g., balance deficits; weakness; depression), measurable markers of functional status. We conducted a pilot study to determine feasibility of recruiting persons age ≥50 seeking SUD treatment and evaluated their mental health and physical function. This pilot study is a first step towards determining the impact of geriatric conditions on SUD treatment-related outcomes (e.g., drop out; continued drug use; hospitalization). Methods Pilot study recruitment occurred between December 2022 and September 2023. Pilot study participants had to be age ≥50. SUD treatment group participants had to be currently receiving SUD treatment at one of 4 community-based outpatient clinics. Control participants were recruited from UConn dental outpatient mental health clinics and could not have a SUD history. All study participants completed face-to-face interviews that took about 1.5 hours. Mental health was assessed using the 7-item Generalized Anxiety Disorders scale (GAD-7), the 8-item Patient Health Questionnaire (PHQ-8), and the Post-Traumatic Stress Disorder Checklist (PCL-5). Objective assessments of physical function included a gait speed assessment, Berg Balance Scale, Tinetti Balance Assessment, and maximum handgrip strength. In addition, participants receiving SUD treatment also completed the 8-item Treatment Progress Assessment (TPA-8) and responded to specific questions about substance use and legal involvement via the Addiction Severity Index (ASI). Study participants were compensated. Results Of 51 persons seeking SUD treatment who were screened, 35 (68.6%) met eligibility criteria and enrolled. Of 17 potential control subjects who were screened; 10 (58.8%) met eligibility criteria and enrolled. Among SUD treatment participants, substances most frequently reported as the major problem were heroin (54.3%), other opiates (14.3%), and cocaine (14.3%), and common chronic conditions included Hepatitis C (52.9%), arthritis (52.9%), and lung disease (38.2%). Scores on the TPA-8 (possible range 8 to 32) ranged from 17 to 32, where higher scores indicate better progress, and average TPA-8 score was 25.1±3.8. Justice involvement in this group was also common; 74.2% had been arrested for drug-related offenses, and 85% of those were convicted. Table 1 presents characteristics of the study participants. As compared with controls, SUD treatment participants were younger; comprised of fewer non-Hispanic Whites; and had fewer years of education. Regarding mental health, SUD treatment participants had higher average GAD-7 and PHQ-8 scores, and 46% had PHQ-8 scores of ≥10 indicating clinical depression. Sum of stressful events was higher for the SUD treatment group. Scores for both balance measures were lower (worse) in the SUD treatment group versus controls, and grip strength, an indicator of overall weakness, was lower in the SUD treatment group. In contrast, gait speed was faster (better) in the SUD treatment group. Conclusions This pilot study demonstrated feasibility of recruiting individuals age ≥50 years who were receiving SUD treatment at community-based outpatient clinics. All participants completed objective measures of function and face-to-face interviews, and there was variability in responses within and between groups. Our findings support moving forward to conduct a larger study to assess how geriatric conditions impact persons seeking SUD treatment in mid-to-late life.
psychiatry,geriatrics & gerontology,gerontology